Discussion about this post

User's avatar
Sarah Walker's avatar

"I agree with you, but I don't believe it's a conspiracy."

'When something bad happens, it's easier to believe someone did that in purpose than to believe that life is hard'

BRB, going to embroider these on pillows.

Amy's avatar
Mar 17Edited

In my personal capacity, I’d like to point out that it would be worthwhile to start to have conversations about how challenging and high risk an investment in vaccine development actually is. This is not/rarely raised in the vaccine discourse but it is a consideration.

For example, unlike therapeutic products which an individual might take consistently over a period of time (more sales = more $), vaccines are often given only a few times, at most, depending on what is needed for durable

Immunity. The clinical trials are also challenging because those aimed at showing efficacy often require a large study so that there is a large enough sample size for the control arm to have subjects infected. (And show that the treatment arm has a lower incidence of infection thus demonstrating efficacy.)

There are other challenges that might be more specific to the infectious agent being targeted. For example, cost and vaccination regimen (how many times must a patient get to a clinic for vaccination/booster shots?) are key when developing vax for use in less affluent communities/countries.

So the idea that companies are easily

Deciding to make vaccines to rake in cash is not realistic. As usual, lack of understanding and nuiance can lead us to poor conclusions and conflict.

Thank you for reading my dissertation 😂 I’m sure you can find commentaries with more detail in scientific publications like Nature.

62 more comments...

No posts

Ready for more?